|
|
|
|
|
 |
|
|
|
ANIMAL AND CELL MODELS FOR
DETECTION AND CHARACTERISATION
OF LEUKEMIC STEM CELLS
|
|
Publications 2014
|
DOCUMENT |
I.F. |
CUARTILE |
|
García-Gutiérrez, V.; Puerta, J. M.; Maestro, B.; Montero, L. F. C.; Muriel, A.; Hurtado, J. R. M.; Pérez-Encinas, M.; Romero, M. V. M.; Sunol, P. B.; García, R. S.; de Paz, R.; Sánchez, M. J. R.; Osorio, S.; Vázquez, M. I. M.; López, J. M.; Sastre, J. L.; Portero, M. D.; Bautista, G.; Nieto, M. S. D.; Giraldo, P.; Jambrina, M. J.; Burgaleta, C.; Aredondo, J. R.; Penarrubia, M. J.; Requena, M. J.; Valle, M. D. F.; Calle, C.; Coll, A. P.; Hernández-Rivas, J. A.; Osorio, R. F.; Cano, P.; Pérez, D. T.; de la Mata, M. F.; Garrido, P. L.; Steegmann, J. L. Do chronic myeloid leukemia patients with late “warning” responses benefit from “watch and wait” or switching therapy to a second generation tyrosine kinase inhibitor? AMERICAN JOURNAL OF HEMATOLOGY. 2014; 89(11): E206-E211. Artículo. |
|
Q2 |
|
García-Manero, G.; Gartenberg, G.; Steensma, D. P.; Schipperus, M. R.; Breems, D. A.; de Paz, R.; Valcarcel, D.; Kranenburg, B.; Reddy, M.; Komrokji, R. S. A phase 2, randomized, double-blind, multicenter study comparing siltuximab plus best supportive care (BSC) with placebo plus BSC in anemic patients with International Prognostic Scoring System low- or intermediate-1-risk myelodysplastic syndrome. AMERICAN JOURNAL OF HEMATOLOGY. 2014; 89(9): E156-E162. Artículo. |
3,798 |
Q2 |
|
Álvarez-Larrán, A.; Bellosillo, B.; Pereira, A.; Kerguelen, A.; Hernández-Boluda, J. C.; Martínez-Avilés, L.; Fernández-Rodríguez, C.; Gómez, M.; Lombardía, L.; Angona, A.; Ancochea, A.; Senin, A.; Longarón, R.; Navarro, B.; Collado, M.; Besses, C. JAK2V617F monitoring in polycythemia vera and essential thrombocythemia: clinical usefulness for predicting myelofibrotic transformation and thrombotic events. AMERICAN JOURNAL OF HEMATOLOGY. 2014; 89(5): 517-523. Artículo. |
3,798 |
Q2 |
|
Geyer, H. L.; Scherber, R. M.; Dueck, A. C.; Kiladjian, J. J.; Xiao, Z. J.; Slot, S.; Zweegman, S.; Sackmann, F.; Fuentes, A. K.; Hernández-Maraver, D.; Dohner, K.; Harrison, C. N.; Radia, D.; Muxi, P.; Besses, C.; Cervantes, F.; Johansson, P. L.; Andreasson, B.; Rambaldi, A.; Barbui, T.; Vannucchi, A. M.; Passamonti, F.; Samuelsson, J.; Birgegard, G.; Mesa, R. A. Distinct clustering of symptomatic burden among myeloproliferative neoplasm patients: retrospective assessment in 1470 patients. BLOOD. 2014; 123(24): 3803-3810. Artículo. |
10,452 |
D1 |
|
Sánchez-García, J.; del Canizo, C.; Lorenzo, I.; Nomdedeu, B.; Luno, E.; de Paz, R.; Xicoy, B.; Valcarcel, D.; Brunet, S.; Marco-Betes, V.; García-Pintos, M.; Osorio, S.; Tormo, M.; Bailén, A.; Cervero, C.; Ramos, F.; Díez-Campelo, M.; Such, E.; Arrizabalaga, B.; Azaceta, G.; Bargay, J.; Arilla, M. J.; Falantes, J.; Serrano-López, J.; Sanz, G. F. Multivariate timedependent comparison of the impact of lenalidomide in lower-risk myelodysplastic syndromes with chromosome 5q deletion. BRITISH JOURNAL OF HAEMATOLOGY. 2014; 166(2): 189-201. Artículo. |
4,711 |
Q1 |
|
Través, P. G.; Pardo, V.; Pimentel-Santillana, M.; González-Rodríguez, A.; Mojena, M.; Rico, D.; Montenegro, Y.; Calés, C.; Martín-Sanz, P.; Valverde, A. M.; Boscá, L. Pivotal role of protein tyrosine phosphatase 1B (PTP1B) in the macrophage response to pro-inflammatory and antiinflammatory challenge. CELL DEATH & DISEASE. 2014; 5: e1125. Artículo. |
5,014 |
Q2 |
|
Monserrat, J.; Sánchez, M. A.; de Paz, R.; Díaz, D.; Mur, S.; Reyes, E.; Prieto, A.; de la Hera, A.; Martínez, C.; Álvarez-Mon, M. Distinctive patterns of naive/memory subset distribution and cytokine expression in CD4 T lymphocytes in ZAP-70 B-chronic lymphocytic patients. CYTOMETRY PART B-CLINICAL CYTOMETRY. 2014; 86(1):32-43. Artículo. |
2,398 |
Q2 |
|
Briones, J.; Novelli, S.; García-Marco, J. A.; Tomás, J. F.; Bernal, T.; Grande, C.; Canales, M. A.; Torres, A.; Moraleda, J. M.; Panizo, C.; Jarque, I.; Palmero, F.; Hernández, M.; González-Barca, E.; López, D.; Caballero, D. Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan plus BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a prospective, multicenter, phase II clinical trial. HAEMATOLOGICA. 2014; 99(3): 505-510. Artículo. |
5,814 |
D1 |
|
Giménez, E.; Besses, C.; Boque, C.; Velez, P.; Kerguelen, A.; Cervantes, F.; Ferrer-Marín, F.; Pérez-Encinas, M.; Rodríguez, M.; González, J. D.; Calzada, R.; Hernández-Boluda, J. C. Indirect and non-medical economic burden, quality-of-life, And disabilities of the myelofibrosis disease in Spain. JOURNAL OF MEDICAL ECONOMICS. 2014; 17(6): 435-441. Artículo. |
1,576 |
Q2 |
|
Xicoy, B.; Jiménez, M. J.; García, O.; Bargay, J.; Martínez-Robles, V.; Brunet, S.; Arilla, M. J.; de Oteyza, J. P.; Andreu, R.; Casano, F. J.; Cervero, C. J.; Bailén, A.; Díez, M.; González, B.; Vicente, A. I.; Pedro, C.; Bernal, T.; Luno, E.; Cedena, M. T.; Palomera, L.; Simiele, A.; Calvo, J. M.; Marco, V.; Gómez, E.; Gómez, M.; Gallardo, D.; Muñoz, J.; de Paz, R.; Grau, J.; Ribera, J. M.; Benlloch, L. E.; Sanz, G. Results of treatment with azacitidine in patients aged >= 75 years included in the Spanish Registry of Myelodysplastic Syndromes. LEUKEMIA & LYMPHOMA. 2014; 55(6): 1300-1303. Artículo. |
2,891 |
Q2 |
|
Pérez-Chacón, G.; de los Ríos, C.; Zapata, J. M. Indole-3-carbinol induces cMYC and IAP-family downmodulation and promotes apoptosis of Epstein-Barr virus (EBV)-positive but not of EBV-negative Burkitt’s lymphoma cell lines. PHARMACOLOGICAL RESEARCH. 2014; 89: 46-56. Artículo. |
4,408 |
Q1 |
|
Sánchez, S. A.; Méndez-Barbero, N.; Santos-Beneit, A. M.; Esteban, V.; Jiménez-Borreguero, L. J.; Campanero, M. R.; Redondo, J. M. Nonlinear optical 3-dimensional method for quantifying atherosclerosis burden. CIRCULATION-CARDIOVASCULAR IMAGING. 2014; 7(3): 566-569. Material Editorial. |
5,316 |
D1 |
|
Román, M. T. A.; Bello, I. F.; Arias-Salgado, E. G.; de Paz, R.; Yuste, V. J.; Salces, M. M.; Butta, N. V. Effect of thrombopoietin-receptor agonists on a proliferation-inducing ligand (APRIL) plasma levels in patients with immune thrombocytopaenia. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2014; 78(3): 674-676. Carta. |
3,878 |
Q1 |
|
Briones, J.; Novelli, S.; García-Marco, J. A.; Tomás, J. F.; Bernal, T.; Grande, C.; Canales, M. A.; Torres, A.; Moraleda, J. M.; Panizo, C.; Jarque, I.; Palmero, F.; Hernández, M.; González-Barca, E.; López, D.; Caballero, D. Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a prospective, multicenter, phase II clinical trial. HAEMATOLOGICA. 2014; 99: 7. Carta. |
5,814 |
D1 |
|
Hernández-Boluda, J. C.; Pereira, A.; Gómez, M.; Boque, C.; Ferrer-Marín, F.; Raya, J. M.; García-Gutiérrez, V.; Kerguelen, A.; Xicoy, B.; Barba, P.; Martínez, J.; Luno, E.; Álvarez-Larran, A.; Martínez-López, J.; Arbelo, E.; Besses, C. The international prognostic scoring system does not accurately discriminate different risk categories in patients with postessential thrombocythemia and post-polycythemia vera myelofibrosis. HAEMATOLOGICA. 2014; 99(4): E55-E57. Carta. |
5,814 |
D1 |
Publications 2009 - 2013
|
YEAR |
NAME |
I.F |
CUARTILE |
|
2013 |
Hernández-Boluda, J. C.; Pereira, A.; Cervantes, F.; Gómez, M.; Arellano-Rodrigo, E.; Álvarez-Larrán, A.; Ferrer-Marín, F.; Kerguelen, A.; Márquez, J. A.; Antelo, M. L.; Besses, C. Clinical evaluation of the European LeukemiaNet response criteria in patients with essential thrombocythemia treated with anagrelide. ANNALS OF HEMATOLOGY. 2013; 92(6): 771-775. Artículo. |
2,396 |
Q3 |
|
2013 |
Sanz, J.; Picardi, A.; Boluda, J. C. H.; Martín, C.; Ferra, C.; Nozzoli, C.; González-Vicent, M.; Rambaldi, A.; Valcárcel, D.; Verdeguer, A.; Serrano, D.; de Heredia, C. D.; Pascual, M. J.; de Paz, R.; Montesinos, P.; Bartolozzi, B.; Algarotti, A.; Sanz, M. A.; Arcese, W.; Sanz, G. F. Impact of graft-versus-host disease prophylaxis on outcomes after myeloablative single-unit umbilical cord blood transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2013; 19(9): 1387-1392. Artículo. |
3,348 |
Q2 |
|
2013 |
Sánchez-Espiridión, B.; Martín-Moreno, A. M.; Montalbán, C.; Figueroa, V.; Vega, F.; Younes, A.; Medeiros, L. J.; Alves, F. J.; Canales, M.; Estévez, M.; Menárguez, J.; Sabín, P.; Ruiz-Marcellán, M. C.; López, A.; Sánchez-Godoy, P.; Burgos, F.; Santonja, C.; López, J. L.; Piris, M. A.; García, J. F. MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma. BRITISH JOURNAL OF HAEMATOLOGY. 2013; 162(3): 336-347. Artículo. |
4,959 |
Q1 |
|
2013 |
Maldonado Cid, P.; Sendagorta Cudós, E.; Noguera Morel, L.; Gómez-Fernández, C.; Beato Merino, M. J.; Hernández-Maraver, D.; Herranz Pinto, P. Acral erythema worsened by intravenous infusions of cyclosporin. DERMATOLOGY ONLINE JOURNAL. 2013; 19(3): 2013-2016. Artículo. |
No Indexada |
No Indexada |
|
2013 |
Méndez-Barbero, N.; Esteban, V.; Villahoz, S.; Escolano, A.; Urso, K.; Alfranca, A.; Rodríguez, C.; Sánchez, S. A.; Osawa, T.; Andrés, V.; Martínez-González, J.; Minami, T.; Redondo, J. M.; Campanero, M. R. A major role for RCAN1 in atherosclerosis progression. EMBO MOLECULAR MEDICINE. 2013; 5(12): 1901-1917. Artículo. |
8,245 |
D1 |
|
2013 |
Arenillas, L.; Mallo, M.; Ramos, F.; Guinta, K.; Barragán, E.; Lumbreras, E.; Larrayoz, M. J.; de Paz, R.; Tormo, M.; Abaigar, M.; Pedro, C.; Cervera, J.; Such, E.; Calasanz, M. J.; Díez-Campelo, M.; Sanz, G. F.; Hernández, J. M.; Luno, E.; Saumell, S.; Maciejewski, J.; Florensa, L.; Sole, F. Single nucleotide polymorphism array karyotyping: a diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testing. GENES CHROMOSOMES & CANCER. 2013; 52(12): 1167-1177. Artículo. |
3,836 |
Q2 |
|
2013 |
Arranz, R.; García-Noblejas, A.; Grande, C.; Cannata-Ortiz, J.; Sánchez, J. J.; García-Marco, J. A.; Aláez, C.; Pérez-Calvo, J.; Martínez-Sánchez, P.; Sánchez-González, B.; Canales, M. A.; Conde, E.; Martín, A.; Arranz, E.; Terol, M. J.; Salar, A.; Caballero, D. First-line treatment with rituximab-hyperCVAD alternating with rituximab-methotrexate-cytarabine and followed by consolidation with Y-90-ibritumomab-tiuxetan in patients with mantle cell lymphoma. Results of a multicenter, phase 2 pilot trial from the GELTAMO group. HAEMATOLOGICA. 2013; 98(10): 1563-1570. Artículo. |
5,868 |
D1 |
|
2013 |
López-Menéndez, C.; Gamir-Morralla, A.; Jurado-Arjona, J.; Higuero, A. M.; Campanero, M. R.; Ferrer, I.; Hernández, F.; Ávila, J.; Díaz-Guerra, M.; Iglesias, T. Kidins220 accumulates with tau in human Alzheimer’s disease and related models: modulation of its calpain-processing by GSK3 beta/PP1 imbalance. HUMAN MOLECULAR GENETICS. 2013; 22(3): 466-482. Artículo. |
6,677 |
D1 |
|
2013 |
Somovilla-Crespo, B.; Alfonso-Pérez, M.; Cuesta-Mateos, C.; Carballo-de Dios, C.; Beltrán, A. E.; Terrón, F.; Pérez-Villar, J. J. ; Gamallo-Amat, C.; Pérez-Chacón, G.; Fernández-Ruiz, E.; Zapata, J. M.; Muñoz-Calleja, C. 1. Anti-CCR7 therapy exerts a potent anti-tumor activity in a xenograft model of human mantle cell lymphoma. JOURNAL OF HEMATOLOGY AND ONCOLOGY. 2013; 6:89. Artículo. |
4,933 |
Q1 |
|
2013 |
Martínez-Forero, I.; Azpilikueta, A.; Bolaños-Mateo, E.; Nistal-Villán, E.; Palazón, A.; Teijeira, A.; Pérez-Chacón, G.; Morales-Kastresana, A.; Murillo, O.; Jure-Kunkel, M.; Zapata, J. M.; Melero, I. T cell costimulation with anti-CD137 monoclonal antibodies is mediated by K63-polyubiquitin-dependent signals from endosomes. JOURNAL OF IMMUNOLOGY. 2013;190(12): 6694-6706. Artículo. |
5,362 |
D1 |
|
2013 |
Paiva, B.; Vidriales, M. B.; Rosinol, L.; Martínez-López, J.; Mateos, M. V.; Ocio, E. M.; Montalbán, M. A.; Cordón, L.; Gutiérrez, N. C.; Corchete, L.; Oriol, A.; Terol, M. J.; Echeveste, M. A.; de Paz, R.; de Arriba, F.; Palomera, L.; de la Rubia, J.; Díaz-Mediavilla, J.; Granell, M.; Gorosquieta, A.; Alegre, A.; Orfao, A.; Lahuerta, J. J.; Blade, J.; Miguel, J. F. S. A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUSlike signature and long-term disease control. LEUKEMIA. 2013;
27(10): 2056-2061. Artículo. |
9,379 |
D1 |
|
2013 |
González-Barca, E.; Canales, M.; Cortés, M.; Vidal, M. J.; Salar, A.; Oriol, A.; Bargay, J.; Bello, J. L.; Sánchez, J. J.; Tomás, J. F.; Donato, E.; Ferrer, S.; Caballero, D. Predictive value of interim F-18-FDG-PET/CT for event-free survival in patients with diffuse large B-cell lymphoma homogenously treated in a phase II trial with six cycles of R-CHOP-14 plus pegfilgrastim as first-line treatment. NUCLEAR MEDICINE COMMUNICATIONS. 2013; 34(10): 946-952. Artículo. |
1,371 |
Q3 |
|
2013 |
Martín, M.; de Paz, R.; Jiménez-Yuste, V.; Bello, I. F.; Salgado, E. G. A.; Álvarez, M. T.; Butta, N. V. Platelet apoptosis and agonist-mediated activation in myelodysplastic syndromes. THROMBOSIS AND HAEMOSTASIS. 2013; 109(5): 909-919. Artículo. |
5,76 |
D1 |
|
2013 |
Herráez Albendea, M. M.; López Rodríguez, M.; López de la Guía, A.; Canales Albendea, M. A. Schnitzler syndrome. REUMATOLOGIA
CLÍNICA. 2013; 9(6): 384. Carta. |
No Indexado |
No Indexado |
|
2013 |
Caballero, D.; Campo, E.; López-Guillermo, A.; Martín, A.; Arranz-Sáez, R.; Gine, E.; López, A.; González-Barca, E.; Canales, M. A.; González-Díaz, M.; Orfao, A. Clinical practice guidelines for diagnosis, treatment, and follow-up of patients with mantle cell lymphoma. Recommendations from the GEL/TAMO Spanish Cooperative Group. ANNALS OF HEMATOLOGY. 2013; 92(9): 1151-1179. Revisión. |
2,396 |
Q3 |
|
2012 |
Fernández-Morales, B.; Pavón, L.; Calés, C. CDC6 expression is regulated by lineage-specifi c transcription factor GATA1. CELL CYCLE. 2012; 11(16): 3055-3066. Article. |
5,243 |
Q1 |
|
2012 |
Pérez-Chacón, G.; Llobet, D.; Pardo, C.; Pindado, J.; Choi, Y.; Reed, J. C.; Zapata, J. M. TNFR-associated factor 2 defi ciency in B lymphocytes predisposes to chronic lymphocytic leukemia/small lymphocytic lymphoma in mice. JOURNAL OF IMMUNOLOGY. 2012; 189(2): 1053-1061. Article. |
5,52 |
Q1 |
|
2012 |
Molina-Privado, I.; Jiménez-P, R.; Montes-Moreno, S.; Chiodo, Y.; Rodríguez-Martínez, M.; Sánchez-Verde, L.; Iglesias, T.; Piris, M. A.; Campanero, M. R. E2F4 plays a key role in Burkitt lymphoma tumorigenesis. LEUKEMIA. 2012; 26(10): 2277-2285. Article. |
10,164 |
D1 |
|
2012 |
Paiva, B.; Vidriales, M. B.; Montalbán, M. A.; Pérez, J. J.; Gutiérrez,
N. C.; Rosinol, L.; Martínez-López, J.; Mateos, M. V.; Cordón, L.; Oriol, A.; Terol, M. J.; Echeveste, M. A.; de Paz, R.; de Arriba, F.; Palomera, L.; de la Rubia, J.; Díaz-Mediavilla, J.; Sureda, A.; Goros Quieta, A.; Alegre, A.; Martín, A.; Lahuerta, J. J.; Blade, J.; Orfao, A.; San Miguel, J. F. Multiparameter flow cytometry evaluation of plasma cell DNA content and proliferation in 595 transplant-eligible patients with myeloma included in the Spanish GEM2000 and GEM2005 < 65y trials.
AMERICAN JOURNAL OF PATHOLOGY. 2012; 181(5): 1870-
1878. Article. |
4,522 |
Q1 |
|
2012 |
Santamaría, C.; Ramos, F.; Puig, N.; Barragan, E.; de Paz, R.; Pedro, C.; Insunza, A.; Tormo, M.; del Canizo, C.; Díez-Campelo, M.; Xicoy, B.; Salido, E.; del Real, J. S.; Hernández, M.; Chillón, C.; Sanz, G. F.; García-Sanz, R.; San Miguel, J.F.; González, M. Simultaneous analysis of the expression of 14 genes with individual prognostic value in myelodysplastic syndrome patients at diagnosis: WT1 detection in peripheral blood adversely affects survival. ANNALS OF HEMATOLOGY. 2012; 91(12): 1887-1895. Article. |
2,866 |
Q2 |
|
2012 |
Paiva, B.; Gutiérrez, N. C.; Rosinol, L.; Vidriales, M. B.; Montalbán,
M. A.; Martínez-López, J.; Mateos, M. V.; Cibeira, M.T.; Cordón, L.; Oriol, A.; Terol, M. J.; Echeveste, M. A.; de Paz, R.; de Arriba, F.; Palomera, L.; de la Rubia, J.; Díaz-Mediavilla, J.; Sureda, A.; Goros Quieta, A.; Alegre, A.; Martín, A.; Hernández, M. T.; Lahuerta, J. J.; Blade, J.; Migue, J. F. S. Highrisk cytogenetics and persistent minimal residual disease by multiparameter fl ow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma. BLOOD. 2012; 119(3): 687-691. Article. |
9,06 |
D1 |
|
2012 |
Rosinol, L.; Oriol, A.; Teruel, A. I.; Hernández, D.; López-Jiménez,
J.; de la Rubia, J.; Granell, M.; Besalduch, J.; Palomera, L.; González, Y.; Etxebeste, M. A.; Díaz-Mediavilla, J.; Hernández, M. T.; de Arriba, F.; Gutiérrez, N. C.; Martín-Ramos, M. L.; Cibeira, M. T.; Mateos, M. V.; Martínez, J.; Alegre, A.; Lahuerta, J. J.; San Miguel, J.; Blade, J. Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized
phase 3 PETHEMA/GEM study. BLOOD. 2012; 120(8):
1589-1596. Article. |
9,06 |
D1 |
|
2012 |
Córdoba, I.; González-Porras, J. R.; Nomdedeu, B.; Luno, E.; de Paz, R.; Such, E.; Tormo, M.; Vallespi, T.; Collado, R.; Xicoy, B.; Andreu, R.; Muñoz, J. A.; Sole, F.; Cervera, J.; del Canizo, C. Better prognosis for patients with del(7. Q) than for patients with monosomy 7 in yelodysplastic syndrome. CANCER. 2012; 118(1): 127-133. Article. |
5,201 |
Q1 |
|
2012 |
Emanuel, R. M.; Dueck, A. C.; Geyer, H. L.; Kiladjian, J. J.; Slot, S.; Zweegman, S.; te Boekhorst, P. A. W.; Commandeur, S.; Schouten, H. C.; Sackmann, F.; Fuentes, A. K.; Hernández-Maraver, D.; Pahl, H. L.; Griesshammer, M.; Stegelmann, F.; Doehner, K.; Lehmann, T.; Bonatz, K.; Reiter, A.; Boyer, F.; Etienne, G.; Ianotto, J. C.; Ranta, D.; Roy, L.; Cahn, J. Y.; Harrison, C. N.; Radia, D.; Muxi, P.; Maldonado, N.; Besses, C.; Cervantes, F.; Johansson, P. L.; Barbui, T.; Barosi, G.; Vannucchi, A. M.; Passamonti, F.; Andreasson, B.; Ferarri, M. L.; Rambaldi, A.; Samuelsson, J.; Birgegard, G.; Tefferi, A.; Mesa, R.
A. Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs. JOURNAL OF CLINICAL ONCOLOGY. 2012; 30(33): 4098-4103. Article. |
18,038 |
D1 |
|
2012 |
Paiva, B.; Gutiérrez, N. C.; Chen, X.; Vidriales, M. B.; Montalbán, M. A.; Rosinol, L.; Oriol, A.; Martínez-López, J.; Mateos, M. V.; López-Corral, L.; Díaz-Rodríguez, E.; Perez, J.J.; Fernández-Redondo, E.; de Arriba, F.; Palomera, L.; Bengoechea, E.; Terol, M. J.; de Paz, R.; Martín, A.; Hernández, J.; Orfao, A.; Lahuerta, J. J.; Blade, J.; Pandiella, A.; San Miguel, J. F. Clinical signifi cance of CD81 expression by clonal
plasma cells in high-risk smoldering and symptomatic multiple myeloma patients. LEUKEMIA. 2012; 26 (8): 1862-1869. Article. |
10,164 |
D1 |
|
2012 |
Guisado-Vasco, P.; Arranz-Sáez, R.; Canales, M.; Canovas, A.; García-Larana, J.; García-Sanz, R.; López, A.; López, J. L.; Llanos, M.; Moraleda, J. M.; Rodríguez, J.; Rayón, C.; Sabín, P.; Salar, A.; Marín-Niebla, A.; Morente, M.; Sánchez-Godoy, P.; Tomas, J. F.; Muriel, A.; Abraira, V.; Piris, M. A.; García, J.F.; Montalbán, C. Stage IV and age over 45 years are the only prognostic factors of the international prognostic score for the outcome of advanced Hodgkin lymphoma in the Spanish Hodgkin Lymphoma Study Group series. LEUKEMIA & LYMPHOMA. 2012; 53(5): 812-819. Article. |
2,301 |
Q3 |
|
2012 |
Córdoba, I.; González-Porras, J. R.; Such, E.; Nomdedeu, B.; Luno, E.; de Paz, R.; Carbonell, F.; Vallespí, T.; Ardanaz, M.; Ramos, F.; Marco, V.; Bonanad, S.; Sánchez-Barba, M.; Costa, D.; Bernal, T.; Sanz, G. F.; Canizo, M. C. The degree of neutropenia has a prognostic impact in low risk myelodysplastic syndrome. LEUKEMIA RESEARCH. 2012; 36(3): 287-292. Article. |
2,764 |
Q2 |
|
2012 |
Fuentes, A. E. K.; Hernández-Maraver, D.; Lombardía, L.; Albendea,
M. A. C.; de la Rúa, A. R. Clinical signifi cance of the quantifi cation of JAK2V617F allele burden in classical Phnegative myeloproliferative neoplasms. MEDICINA CLÍNICA. 2012; 139(9): 373-378. Article. |
1,399 |
Q2 |
|
2012 |
Arrieta, J. M. L.; de Paz, R.; Altes, A.; del Canizo, C. Myelodysplastic
syndrome in the elderly: comprehensive geriatric assessment and therapeutic recommendations. MEDICINA CLÍNICA. 2012; 138(3): 119-119. Editorial Material. |
1,399 |
Q2 |
|
2012 |
Oreiro, M. B.; Castilla-Llorente, C.; de la Guía, A.; de Paz, R.; Van Domselaar, M.; Nieto, J.; Rodríguez, A.; Gallardo, D.; Canales, M. Fecal calprotectin in allogeneic stem cell transplantation for the diagnosis of acute intestinal graft versus host disease. BONE MARROW TRANSPLANTATION. 2012; 47(9): 1241-1242. Letter. |
3,541 |
Q2
|
|
2011 |
González-Porras, J. R.; Córdoba, I.; Such, E.; Nomdedeu, B.; Vallespi,
T.; Carbonell, F.; Luno, E.; Ardanaz, M.; Ramos, F.; Pedro, C.; Gómez, V.; de Paz, R.; Sánchez-Barba, M.; Sanz, G. F.; del Canizo, C. Prognostic
impact of severe thrombocytopenia in low-risk myelodysplastic syndrome.
CANCER. 2011; 117(24): 5529-5537. Article. |
4,771 |
Q1 |
|
2011 |
Konuma, T.; Nakamura, S.; Miyagi, S.; Negishi, M.; Chiba, T.; Oguro,
H.; Yuan, J.; Mochizuki-Kashio, M.; Ichikawa, H.; Miyoshi, H.; Vidal, M.;
Iwama, A. Forced expression of the histone demethylase Fbxl10 maintains, self-renewing hematopoietic stem cells. EXPERIMENTAL HEMATOLOGY. 2011; 39(6): 697-709. Article. |
2,905 |
Q2 |
|
2011 |
García-Tuñon, I.; Guallar, D.; Alonso-Martín, S.; Benito, A. A.; Benítez-
Lázaro, A.; Pérez-Palacios, R.; Muniesa, P.; Climent, M.; Sánchez, M.;
Vidal, M.; Schoorlemmer, J. Association of Rex-1 to target genes supports its interaction with Polycomb function. STEM CELL RESEARCH. 2011; 7(1): 1-16. Article. |
5,127 |
Q1 |
|
2011 |
Jean-Mairet, R. M.; López-Menéndez, C.; Sánchez-Ruiloba, L.; Sacristán, S.; Rodríguez-Martínez, M.; Riol-Blanco, L.; Sánchez-Mateos, P.; Sánchez-Madrid, F.; Rodríguez-Fernández, J. L.; Campanero, M. R.; Iglesias, T. The neuronal protein Kidins220/ARMS associates with ICAM-3 and other uropod components and regulates T-cell motility. EUROPEAN
JOURNAL OF IMMUNOLOGY. 2011; 41(4): 1035-1046. Article. |
5,103 |
Q1 |
|
2011 |
Vallespinos, M.; Fernández, D.; Rodríguez, L.; Álvaro-Blanco, J.; Baena,
E.; Ortiz, M.; Dukovska, D.; Martínez, D.; Rojas, A.; Campanero, M. R.; de Alborán, I. M. B Lymphocyte Commitment Program Is Driven by the Proto-Oncogene c-myc. JOURNAL OF IMMUNOLOGY. 2011; 186(12): 6726-6736. Article. |
5,788 |
Q1 |
|
2010 |
Cuesta-Mateos, C; López-Giral, S; Alfonso-Pérez, M; de Soria, VGG; Loscertales, J; Guasch-Vidal, S; Beltran, AE; Zapata, JM; Munoz-Calleja, C. Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leucemia. EXPERIMENTAL HEMATOLOGY. 2010; 38(9): 756-764. Article. |
3,198 |
Q2 |
|
2010 |
Mateos, MV; Oriol, A; Martínez-López, J; Gutiérrez, N; Teruel, AI; de Paz, R; García-Larana, J; Bengoechea, E; Martín, A; Mediavilla, JD; Palomera, L; de Arriba, F; González, Y; Hernández, JM; Sureda, A; Bello, JL; Bargay, J; Penalver, FJ; Ribera, JM; Martín-Mateos, ML; García-Sanz, R; Cibeira, MT; Ramos, MLM; Vidriales, MB; Paiva, B; Montalban, MA; Lahuerta, JJ; Blade, J; San Miguel, JF. Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial. LANCET ONCOLOGY. 2010; 11(10): 934-941. Article. |
17,764 |
Q1 |
|
2009 |
Neira, JL; Roman-Trufero, M; Contreras, LM; Prieto, J; Singh, G; Barrera, FN; Renart, ML; Vidal, M. The Transcriptional Repressor RYBP Is a Natively Unfolded Protein Which Folds upon Binding to DNA. BIOCHEMISTRY. 2009; 48(6): 1348-1360 |
3,226 |
Q2
|
|
2009 |
Vidal, M. Role of polycomb proteins Ring1A and Ring1B in the epigenetic regulation of gene expression. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY. 2009; 53(40239): 355-370 |
2,161 |
Q3
|
|
2009 |
Roman-Trufero, M; Mendez-Gomez, HR; Perez, C; Hijikata, A; Fujimura, Y; Endo, T; Koseki, H; Vicario-Abejon, C; Vidal, M. Maintenance of Undifferentiated State and Self-Renewal of Embryonic Neural Stem Cells by Polycomb Protein Ring1B. STEM CELLS. 2009; 27(7): 1559-1570 |
7,747 |
Q1
|
|
|
|
|